Annarita Milone Selected Research

Conduct Disorder (Conduct Disorders)

12/2021	Neuropsychological Characterization of Aggressive Behavior in Children and Adolescents with CD/ODD and Effects of Single Doses of Medications: The Protocol of the Matrics_WP6-1 Study.
1/2018	Trajectories of callous-unemotional traits from childhood to adolescence in referred youth with a disruptive behavior disorder who received intensive multimodal therapy in childhood.
10/2015	Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.
4/2015	Use of quetiapine in children and adolescents.
10/2013	Response to treatments in youth with disruptive behavior disorders.
10/2013	Quetiapine monotherapy in adolescents with bipolar disorder comorbid with conduct disorder.
1/2009	Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study.
1/2006	Olanzapine treatment in adolescents with severe conduct disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annarita Milone Research Topics

Disease

8	Conduct Disorder (Conduct Disorders) 12/2021 - 01/2006
7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2022 - 04/2016
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2019 - 10/2013
4	Oppositional Defiant Disorder 10/2017 - 10/2013
4	Mental Disorders (Mental Disorder) 05/2016 - 01/2006
2	Autism Spectrum Disorder 05/2021 - 04/2015
2	Schizophrenia (Dementia Praecox) 10/2017 - 01/2009
2	Mood Disorders (Mood Disorder) 10/2017 - 01/2009
2	Weight Gain 10/2017 - 04/2015
1	Antisocial Personality Disorder (Antisocial Personality) 12/2021
1	Kleine-Levin Syndrome (Syndrome, Kleine-Levin) 01/2019
1	Neutropenia 01/2019
1	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 01/2018
1	Personality Disorders (Personality Disorder) 04/2015
1	Tourette Syndrome (Tourette's Syndrome) 04/2015
1	Psychotic Disorders (Schizoaffective Disorder) 04/2015
1	Rhabdomyolysis 12/2014
1	Neuroleptic Malignant Syndrome 12/2014
1	Polydipsia 01/2009
1	Tremor (Tremors) 01/2009

Drug/Important Bio-Agent (IBA)

6	Antipsychotic Agents (Antipsychotics)IBA 10/2017 - 12/2014
4	Methylphenidate (Ritalin)FDA LinkGeneric 10/2021 - 04/2016
3	Pharmaceutical PreparationsIBA 07/2021 - 12/2014
3	LithiumIBA 01/2019 - 01/2009
3	Quetiapine Fumarate (Seroquel)FDA Link 10/2015 - 10/2013
2	Biological ProductsIBA 10/2021 - 01/2006
2	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2017 - 10/2015
2	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 10/2013 - 10/2013
2	mesoglycanIBA 04/2009 - 01/2006
1	Immunoglobulin D (IgD)IBA 03/2022
1	BESIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Clozapine (Clozaril)FDA LinkGeneric 01/2019
1	ProlactinIBA 10/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	LipidsIBA 04/2015
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2014
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2009
1	Olanzapine (Zyprexa)FDA Link 01/2006

Therapy/Procedure

3	Therapeutics 12/2021 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2019
1	Intramuscular Injections 12/2014
1	Combined Modality Therapy 10/2013